AstraZeneca Pharma India Ltd.
ShareASTRAZEN Competitor Analysis
| ASTRAZEN | SUNPHARMA  | DIVISLAB | TORNTPHARM | CIPLA | |
|---|---|---|---|---|---|
Overview | |||||
| Current price (₹) As on 21 Nov, 2025, 02:09 PM | 8,917.50 0% | 1,784.50 0% | 6,412.50 0% | 3,699.10 0% | 1,522.50 0% |
| Market cap (₹ Cr) | 22,294 | 4,28,161 | 1,70,232 | 1,25,194 | 1,22,981 |
Past ReturnsAbsolute Returns Shown | |||||
| 1D | -1.12% | -0.29% | -0.69% | -0.75% | -1.37% |
| 1W | -2.63% | 1.54% | -0.71% | -0.88% | -0.32% |
| 1M | -3.28% | 4.16% | -1.98% | 6.17% | -7.6% |
| 3M | 6.81% | 7.7% | 7.8% | 3.47% | -2.04% |
| 6M | 14.07% | 2.99% | 0.33% | 16.95% | 4.13% |
| 1Y | 39.11% | -1.04% | 9.7% | 22.49% | 2.92% |
| 5Y | 105.54% | 249.49% | 86.6% | 190.49% | 104.69% |
Income StatementAnnual data as on 13 Dec 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Sales | 1,716 32.41% | 52,578 8.41% | 9,360 19.31% | 11,516 7.35% | 27,548 6.88% |
| OPM (%) | 14.46 4.33% | 28 7.2% | 30.56 13.44% | 32.25 3.3% | 25.09 5.78% |
| PBT | 156.36 -28.78% | 13,752 24.03% | 2,916 34.81% | 2,673 13.65% | 6,821 19.62% |
PAT | 115.74 -28.34% | 10,980 13.81% | 2,191 36.94% | 1,911 15.4% | 5,291 27.34% |
| Net Profit Margin | 6.74 -45.95% | 20.85 5.2% | 23.41 14.75% | 16.6 7.51% | 19.13 18.67% |
| EPS | 46.3 -28.33% | 45.55 14.13% | 82.53 36.93% | 56.47 15.39% | 65.28 27.87% |
Balance Sheet & Cash FlowAnnual data as on 13 Dec 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Net Worth | 770.35 8.21% | 72,218 13.43% | 14,969 10.3% | 7,591 10.72% | 31,193 16.8% |
| Total Assets | 1,518 40.82% | 92,101 7.77% | 16,932 9.45% | 14,990 -0.47% | 37,387 14.27% |
| Total Outside Liabilities | 747.77 104.25% | 19,883 -8.78% | 1,963 3.37% | 7,399 -9.81% | 6,194 3.04% |
| Cash from Operating Activity | 65.36 134.52% | 14,072 15.96% | 1,653 31.09% | 2,585 -20.85% | 5,005 21.07% |
| Cash from Investment Activity | 30.8 41.67% | -5,306 -668.76% | -804 -198.88% | -540.05 -221.65% | -3,691 -23.53% |
| Cash from Financing Activity | -65.59 -47.79% | -7,906 -17.82% | -799 0% | -2,298 17.34% | -1,293 -7.75% |
| Net Cash Flow | 30.57 484.51% | 983.12 -78.91% | 50 -74.09% | -261.66 -180.11% | 30.31 161.87% |
RatiosAnnual data as on 13 Dec 2025. | |||||
| PB | 27.93 | 5.77 | 10.22 | 14.42 | 3.73 |
| PE | 192.62 | 39.18 | 77.70 | 65.50 | 23.32 |
| ROE (%) | 15.62 | 16.16 | 15.35 | 26.46 | 18.28 |
| Dividend Yield (%) | 0.36 | 0.90 | 0.47 | 0.87 | 1.05 |
| ROCE (%) | 34.35 | 20.86 | 20.45 | 27.55 | 23.64 |
